H6H
SUPN icon

Hightower 6M Holding’s Supernus Pharmaceuticals SUPN Stock Holding History

Hightower 6M Holding’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$208K Buy
+6,141
New +$200K 0.02% 202
2022
Q2 		– Sell
-6,721
Closed -$217K – 385
2022
Q1 		$217K Buy
+6,721
New +$206K 0.02% 312

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hightower 6M Holding's SUPN Position: Q3 2022 in Review

Hightower 6M Holding opened a new position in Supernus Pharmaceuticals (SUPN) in Q3 2022: 6,141 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #202 among its holdings. This is a return to the name: Hightower 6M Holding previously reported a position in SUPN as recently as Q1 2022.

Hightower 6M Holding first reported a position in SUPN in Q1 2022 and has held it in 2 quarters since. The position peaked at $217K in Q1 2022. 244 funds tracked by Wall St. Rank hold SUPN as of Q3 2022.

  • Hightower 6M Holding held 6,141 shares of Supernus Pharmaceuticals worth $208K as of Q3 2022.
  • Supernus Pharmaceuticals was a new Hightower 6M Holding position in Q3 2022.
  • Supernus Pharmaceuticals made up 0.02% of Hightower 6M Holding's portfolio in Q3 2022, its #202 holding.
  • Hightower 6M Holding first reported a position in Supernus Pharmaceuticals in Q1 2022 and has held it in 2 quarters since.
  • Hightower 6M Holding's Supernus Pharmaceuticals position peaked at $217K in Q1 2022.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.